Skip to main content
Equibles

Merck & Co., Inc.

Position in XLO — Xilio Therapeutics, Inc.

CIK 310158 RAHWAY, NJ
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,015,307
+$123,999 QoQ
Shares Held
105,982
0.0% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#9
of 26 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Merck & Co., Inc. holds $338,204,928 across 12 Biotechnology names. XLO ranks #10 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 2,308,190 $161,642,545
2 KYMR
Kymera Therapeutics, Inc.
 772,165 $88,544,160
3 AKTS
Aktis Oncology, Inc.
 952,844 $30,710,162
4 EIKN
Eikon Therapeutics, Inc.
 1,666,666 $21,749,991
5 TRDA
Entrada Therapeutics, Inc.
 1,739,768 $12,804,692
6 STRO
Sutro Biopharma, Inc.
 272,351 $9,042,053
7 ALEC
Alector, Inc.
 3,545,719 $7,126,895
8 EVAX
Evaxion A/S
 1,214,126 $3,763,790

All Filings in XLO

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,015,307 105,982
2026-03-31 $891,308 105,982
2025-12-31 $949,605 1,483,758
2025-09-30 $1,250,807 1,483,758
2025-06-30 $1,008,955 1,483,758
2025-03-31 $1,074,240 1,483,758
2024-12-31 $1,416,988 1,483,758